{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:56:37Z","timestamp":1783025797261,"version":"3.54.6"},"reference-count":29,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"American Society of Hematology\u2019s Minority Hematology Graduate Award","award":["U5GM104938"],"award-info":[{"award-number":["U5GM104938"]}]},{"name":"American Society of Hematology\u2019s Minority Hematology Graduate Award","award":["1K01HL135466-23S1"],"award-info":[{"award-number":["1K01HL135466-23S1"]}]},{"name":"National Institute of General Medical Sciences","award":["U5GM104938"],"award-info":[{"award-number":["U5GM104938"]}]},{"name":"National Institute of General Medical Sciences","award":["1K01HL135466-23S1"],"award-info":[{"award-number":["1K01HL135466-23S1"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U5GM104938"],"award-info":[{"award-number":["U5GM104938"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K01HL135466-23S1"],"award-info":[{"award-number":["1K01HL135466-23S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Managing primary immune thrombocytopenia (ITP) in pregnancy is challenging. Providers must balance bleeding risk against medication toxicity. The evaluation of the implementation of pregnancy-specific ITP clinical guidelines has not been widely studied. The goal of this study was to describe the implementation of pregnancy-specific ITP guidelines at an academic health center. Methods: We conducted a retrospective chart review at the University of Oklahoma Health system from 2011 to 2020. Descriptive statistics were calculated to summarize the characteristics of the study population. Management, according to the clinical guidelines (American Society of Hematology; American College of Obstetricians and Gynecologists) was evaluated during pregnancy and during\/for delivery. Results: A total of 85 pregnant persons with ITP were included. The majority (68%; 58\/85) delivered vaginally. There were 0 maternal deaths and 2 infant deaths. No patients had major bleeding during pregnancy. Postpartum hemorrhage was experienced by 14%. The management of thrombocytopenia during pregnancy was 100% adherent to the strong recommendation for severe (n = 13) and mild (n = 11) thrombocytopenia. However, 18\/50 (36%) asymptomatic persons with moderate thrombocytopenia received treatment despite the strong recommendation that treatment was unnecessary. Additionally, 8\/21 (38%) persons with moderate thrombocytopenia received treatment to increase platelet counts for epidural anesthesia despite the guideline\u2019s suggestion that it was unnecessary. Conclusions: During pregnancy, patients with severe thrombocytopenia (i.e., most at risk of bleeding) received treatment. On the other hand, approximately 40% of pregnant persons with ITP received unnecessary treatment for moderate asymptomatic thrombocytopenia either during pregnancy or for an epidural. Utilizing clinical practice guidelines would reduce the overtreatment of pregnant persons which would reduce the potential side effects of therapy for the mother and infant.<\/jats:p>","DOI":"10.3390\/jcm13216477","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T06:29:57Z","timestamp":1730183397000},"page":"6477","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Implementation of Primary Immune Thrombocytopenia Clinical Practice Guidelines for Management of Pregnancy"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6936-7146","authenticated-orcid":false,"given":"Amanda J.","family":"Llaneza","sequence":"first","affiliation":[{"name":"Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5784-9203","authenticated-orcid":false,"given":"Laura A.","family":"Beebe","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis E.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall K.","family":"Cheney","sequence":"additional","affiliation":[{"name":"Department of Health and Exercise Science, University of Oklahoma, Norman, OK 73019, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6945-3743","authenticated-orcid":false,"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0794-5851","authenticated-orcid":false,"given":"Deirdra R.","family":"Terrell","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Singh, A., Uzun, G., and Bakchoul, T. (2021). Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040789"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/17474086.2020.1711729","article-title":"Management of immune thrombocytopenia in women: Current standards and special considerations","volume":"13","author":"Rodeghiero","year":"2020","journal-title":"Expert Rev. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","article-title":"Clinical updates in adult immune thrombocytopenia","volume":"129","author":"Lambert","year":"2017","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ajh.21616","article-title":"The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports","volume":"85","author":"Terrell","year":"2010","journal-title":"Am. J. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ajh.23262","article-title":"Prevalence of primary immune thrombocytopenia in Oklahoma","volume":"87","author":"Terrell","year":"2012","journal-title":"Am. J. Hematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1753495X17727408","article-title":"Maternal and fetal outcomes of primary immune thrombocytopenia during pregnancy: A retrospective study","volume":"11","author":"Gilmore","year":"2018","journal-title":"Obstet. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Committee on Practice Bulletins\u2014Obstetrics (2019). ACOG Practice Bulletin No. 207: Thrombocytopenia in Pregnancy. Obstet. Gynecol., 133, e181\u2013e193.","DOI":"10.1097\/AOG.0000000000003100"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/aob-20-58","article-title":"Management of immune thrombocytopenia in pregnancy","volume":"6","author":"Poston","year":"2021","journal-title":"Ann. Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.rdc.2017.04.013","article-title":"A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes","volume":"43","author":"Bandoli","year":"2017","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1182\/blood.2020007594","article-title":"Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: Results from a multicenter study","volume":"136","author":"Michel","year":"2020","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood-2017-01-761262","article-title":"A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy","volume":"130","author":"Kong","year":"2017","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/bloodadvances.2020001755","article-title":"A user guide to the American Society of Hematology clinical practice guidelines","volume":"4","author":"Izcovich","year":"2020","journal-title":"Blood Adv."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/bloodadvances.2023011102","article-title":"Distinguishing ASH clinical practice guidelines from other forms of ASH clinical advice","volume":"8","author":"Cuker","year":"2024","journal-title":"Blood Adv."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Graham, R., Mancher, M., Miller Wolman, D., Greenfield, S., and Steinberg, E. (2011). Clinical Practice Guidelines We Can Trust, National Academies Press.","DOI":"10.17226\/13058"},{"key":"ref_20","unstructured":"Smedley, B.D., Stith, A.Y., and Nelson, A.R. (2003). Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care, National Academies Press."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ajh.23226","article-title":"Determining a definite diagnosis of primary immune thrombocytopenia by medical record review","volume":"87","author":"Terrell","year":"2012","journal-title":"Am. J. Hematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ajh.10445","article-title":"Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: A data validation study","volume":"75","author":"Segal","year":"2004","journal-title":"Am. J. Hematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1802897","article-title":"Platelet Counts during Pregnancy","volume":"379","author":"Reese","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"123s","DOI":"10.1378\/chest.08-0654","article-title":"Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Guyatt","year":"2008","journal-title":"Chest"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/AOG.0000000000004972","article-title":"Postpartum Hemorrhage Trends and Outcomes in the United States, 2000-2019","volume":"141","author":"Friedman","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/1471-0528.14697","article-title":"Severe primary autoimmune thrombocytopenia in pregnancy: A national cohort study","volume":"125","author":"Care","year":"2018","journal-title":"BJOG"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ajh.26045","article-title":"Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment","volume":"96","author":"Cooper","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.publhealth.031308.100049","article-title":"Diffusion theory and knowledge dissemination, utilization, and integration in public health","volume":"30","author":"Green","year":"2009","journal-title":"Annu. Rev. Public Health"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/21\/6477\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:22:55Z","timestamp":1760113375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/21\/6477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":29,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["jcm13216477"],"URL":"https:\/\/doi.org\/10.3390\/jcm13216477","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]}}}